TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 1 | -4 | -7 | -15 | -12 | 22 | -3 |
| S | %wins | 50 | 100 | 100 | 100 | 100 | 0 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/26/13 13:18 | 8/22/13 | SCLN | Sciclone Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Yin Min | CA | O | VP Compl | M.d | 46 | 4.21 | 3 | 11 | 0 | D | 21 | 15 | 24 | 12 | -4 | -12 | 1 | -1 | 1 | -4 | -7 | -14 | -13 | 27 | |
8/26/13 13:18 | 8/22/13 | SCLN | Sciclone Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Yin Min | CA | O | VP Compl | S.d | -60 | 5.50 | 3 | -11 | -100 | 0 | D | 21 | 15 | 24 | 12 | -4 | -12 | 1 | -1 | 1 | -4 | -7 | -14 | -13 | 27 |
8/22/13 13:36 | 8/20/13 | SCLN | Sciclone Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Yin Min | CA | O | VP Compl | M.d | 53 | 4.23 | 3 | 13 | 0 | D | 17 | 14 | 13 | 15 | -4 | -10 | -5 | 2 | 0 | -3 | -7 | -16 | -11 | 16 | |
8/22/13 13:36 | 8/20/13 | SCLN | Sciclone Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Yin Min | CA | O | VP Compl | S.d | -69 | 5.50 | 3 | -13 | -100 | 0 | D | 17 | 14 | 13 | 15 | -4 | -10 | -5 | 2 | 0 | -3 | -7 | -16 | -11 | 16 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |